It is a pharma private limited company based in New Delhi, Delhi, India, established in 2006.
2006 | New Delhi, Delhi, India | ActiveMaxlife Drugs Private Limited., a active private limited company, was established on 25 May 2006 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U85121DL2006PTC149174. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.30 M and a paid-up capital of ₹0.15 M.
It upholds a compliant status. Its leadership includes Ganga Saran Sharma (Director), Shashi Sharma (Director), Ankur Sharma (Director). Past directors included Ganga Saran Sharma, Shashi Sharma, Ankur Sharma. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 7, F-204, Aditya Complex, Preet Vihar, New Delhi, Delhi, 110092.
U85121DL2006PTC149174
149174
25 May 2006
₹0.30 M
₹0.15 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Maxlife Drugs Private Limited. — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ganga Saran Sharma | Director | 09 Jan 2024 | Current |
| Shashi Sharma | Director | 09 Jan 2024 | Current |
| Ankur Sharma | Director | 09 Jan 2024 | Current |
| Ankit Sharma | Director | 09 Jan 2024 | Current |
| Navneet Bhardwaj | Director | 27 May 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 09 Jan 2024 | Past |
| Pramod Abcsdd | Director | 23 Oct 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Maxlife Drugs Private Limited., for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1238.37% decrease in profit. The company's net worth observed a substantial decline by a decrease of 104.33%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Maxlife Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Maxlife Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Maxlife Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxlife Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Maxlife Drugs Private Limited. last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Navneet Bhardwaj was appointed as a Director was appointed as a Director on 27 May 2024 & has been associated with this company since 1 year 6 months . was completed.
Progress on Maxlife Drugs Private Limited. has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity Ganga Saran Sharma was appointed as a Director was appointed as a Director on 09 Jan 2024 & has been associated with this company since 1 year 10 months . was completed.
Progress on Shashi Sharma was appointed as a Director was appointed as a Director on 09 Jan 2024 & has been associated with this company since 1 year 10 months . was documented.
Progress on Ankur Sharma was appointed as a Director was appointed as a Director on 09 Jan 2024 & has been associated with this company since 1 year 10 months . was documented.
The CIN of Maxlife Drugs Private Limited. is U85121DL2006PTC149174.
Maxlife Drugs Private Limited. is headquartered at Plot No. 7, F-204, Aditya Complex, Preet Vihar, New Delhi, Delhi, 110092.
Maxlife Drugs Private Limited. was incorporated on 25 May 2006.
The current directors of Maxlife Drugs Private Limited. are
The primary industry of Maxlife Drugs Private Limited. is Trade.
Maxlife Drugs Private Limited. is unlisted.
The authorized capital of Maxlife Drugs Private Limited. is ₹0.30 M, and the paid-up capital is ₹0.15 M.
The compliance status of Maxlife Drugs Private Limited. is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX